In anticipation of the development of novel therapeutic strategies for locally advanced cervical cancer, the present study aimed to determine whether HIF-1α, CA-IX, GLUT-1 or VEGF were associated with the clinicopathological characteristics, lymph node metastasis or progression-free survival of patients with cervical carcinoma. The gene discussed is VEGFA; the disease is cervical cancer.